Adaptive Phase II Study to Evaluate the Safety & Efficacy of NaBen®
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Robert Findling, MD
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Principal InvestigatorKOL profile →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
23 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Chang Gung Memorial Hospital (linkou)
New Taipei City, Taiwan
- Chang Gung Memorial Hospital (taipei)
Taipei, Taiwan
- Veteran General Hospital Taipei
Taipei, Taiwan
- Harmonex Neuroscience Research
Dothan, Alabama, United States
- Citrials
Bellflower, California, United States
- Renew Behavioral Health, Inc.
Long Beach, California, United States
- Citrials
Riverside, California, United States
- Institute of Living/hartford Hospital
Hartford, Connecticut, United States
- Children'S National Health System
Washington D.C., District of Columbia, United States
- Premier Clinical Research Institute
Miami, Florida, United States
- Medical Research Group of Central Florida
Orange City, Florida, United States
- Atlanta Center for Medical Research
Atlanta, Georgia, United States
- John Hopkins University - Hugo W Moser Research Institute at Kennedy Krieger Inc.
Baltimore, Maryland, United States
- University of Massachusetts Medical School - Psychiatry Department
Worcester, Massachusetts, United States
- Michigan Clinical Research Institute
Ann Arbor, Michigan, United States
- University of Minnesota Medical Center - Department of Psychiatry
Minneapolis, Minnesota, United States
- Precise Research Centers
Flowood, Mississippi, United States
- Finger Lakes Clinical Research
Rochester, New York, United States
- University of Cincinnati - Dept. of Psychiatry and Behavioral Neuroscience
Cincinnati, Ohio, United States
- University Hospitals Case Medical Center
Cleveland, Ohio, United States
- Focus and Balance Llc
San Antonio, Texas, United States
- Pacific Institute of Medical Sciences
Bothell, Washington, United States
- Zain Research, Llc
Richland, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2014
- Primary completion
- 26 Oct 2023
- Completion
- 26 Oct 2023
- Last update posted
- 9 May 2024
- Registered enrollment
- 60
- Registry id
- NCT01908192
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.